Showing results (561-570 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|January 1, 1990
Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studiesR von Frenckell, M Ansseau, C Serre, et al.International Clinical Psychopharmacology|April 1, 1990
Pharmacokinetic and pharmacodynamic effects of a single nocturnal dose of alprazolamT R Norman, G D Burrows, I M McIntyreInternational Clinical Psychopharmacology|May 29, 2009
Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1Anna Secher, Jens Bukh, Camilla Bock, et al.International Clinical Psychopharmacology|March 20, 2012
Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trialTong Zhao, Tae-Won Park, Jong-Chul Yang, et al.International Clinical Psychopharmacology|January 14, 2012
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trialChul-Hyun Park, Tae-Won Park, Jong-Chul Yang, et al.International Clinical Psychopharmacology|February 5, 2022
Oxcarbazepine versus sodium valproate in treatment of acute mania: a double-blind randomized clinical trialAli Talaei, Masumeh Sadat Dastgheib, Atefeh Soltanifar, et al.International Clinical Psychopharmacology|February 22, 2022
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed featuresPaolo Olgiati, Giuseppe Fanelli, Alessandro SerrettiInternational Clinical Psychopharmacology|February 10, 2022
Case series on aripiprazole and dopamine supersensitivity psychosisGeoffrey Russell, Samuel Reinfeld, Olivia Kam, et al.International Clinical Psychopharmacology|January 1, 1987
Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamineJ A den Boer, H G Westenberg, W D Kamerbeek, et al.International Clinical Psychopharmacology|October 15, 2019
Differential core pharmacotherapy in bipolar I versus bipolar II disorder and European versus American patients not in a syndromal episodeBernardo Dell'Osso, Laura Cremaschi, Chiara Arici, et al.Pageof 212